biotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to Commercialization
October 18, 2016 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- biotricity inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
July 12, 2016 09:30 ET
|
Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
September 01, 2015 16:00 ET
|
Wright Medical Group N.V.
First Clinically Proven, Cost-Effective Alternative to Autograft for Ankle and/or Hindfoot Fusion Indications Company Can Now Initiate Commercial Sale and Distribution of AUGMENT® Bone Graft in the...
BioCorRx, Inc. CFO, Lourdes Felix discusses 10-K Filing for 2013
April 15, 2014 16:31 ET
|
BioCorRx
Los Angeles, April 15, 2014 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), a leader in addiction treatment programs,
announces its financial results for the 12 months ending December
31,...
Kelyniam Global Inc. Announces Second Quarter 2012 Revenues
October 15, 2012 09:29 ET
|
Kelyniam Global Inc.
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results
Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June
30th 2012 Kelyniam Global Inc. reported a loss of
$45,692...
U.S Food and Drug Administration Clears PositiveID's iglucose System for Diabetes Management
November 16, 2011 08:30 ET
|
PositiveID Corporation
iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management
PositiveID to Begin Commercialization Efforts in First Quarter 2012
DELRAY BEACH, Fla., Nov. 16, 2011 (GLOBE...
Michelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) Clearance
January 12, 2010 14:00 ET
|
Michelson Diagnostics
ORPINGTON, United Kingdom, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, announced today...
Celltech Group plc Submits Xyrem for Approval in Europe
April 01, 2004 01:02 ET
|
Celltech Group plc
SLOUGH, U.K., April 1, 2004 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announces that the European Medicines Evaluation Agency (EMEA) has accepted for review its marketing...